Prostatic acid phosphatase (ACPP) is a glycoprotein that is mainly synthesized and secreted by glandular epithelial cells (GE) of the prostate, and it is well known as a biomarker for prostate cancer. Although ACPP was used as prognostic/ diagnostic indicator and studied to elucidate regulatory mechanism(s) during several decades in humans, its role is not clearly understood. Gene profiling data using a chicken DNA microarray revealed that ACPP increased significantly during remodeling and recrudescence of the oviduct in response to estrogen. Thus, in this study, we investigated the expression and hormonal regulation of ACPP gene in the reproductive tracts of chickens. ACPP was specifically detected in the luminal cells (LE) and GE of chicken oviduct, and diethylstilbestrol (a synthetic nonsteroidal estrogen) stimulated its expression during development of the oviduct. In addition, ACPP mRNA and protein were localized to LE and GE during the regeneration phase of the oviduct of laying hens during induced molting. Furthermore, ACPP mRNA and protein were abundant in GE of ovarian carcinoma, but not in normal ovaries. Moreover, strong expression of ACPP protein was detected in epithelial cells of cancerous ovaries from women. Collectively, results of the present study are the first to show that ACPP is a novel estrogenstimulated gene in the oviductal epithelial cells of the chicken and that its expression increases significantly in epithelial cells of ovarian carcinoma, which indicates that it may be a candidate biomarker for diagnosis of epithelia-derived ovarian cancer in women.
INTRODUCTION
Prostatic acid phosphatase (ACPP) plays an essential role in cell growth and proliferation in the prostate, and it is a wellknown biomarker for the diagnosis and treatment of prostate cancer. In the human genome, the ACPP gene is located on chromosome 3q21-23 and encodes for a 41-kDa mature protein [1] with high sequence homology to ACCP genes in other mammalian species, such as monkey (94%), mouse (83%), and rat (80%) [2] . ACPP is a secretory protein from columnar epithelial cells of the prostate in response to testosterone and several transcription factors, including nuclear factor kappa-light-chain-enhancer of activated B cells, tumor necrosis factor alpha, and interleukin 1 [3] . However, the elaborate regulatory mechanism(s) underlying hormonal and molecular regulation of ACPP gene expression are not fully understood. Expression of the ACPP gene has not been reported for any avian species because birds do not have a prostate gland. In addition, there are no reports of expression and regulation of ACPP gene in female reproductive organs of any species. Recently, Dunn and colleagues found that ACPP significantly increased in the shell gland of the oviduct from mature hens as compared to immature chicks, and they suggested that it may be involved in maintenance of sperm storage and function after insemination in sperm nests in the oviduct of laying hens [4] . In our previous two studies using DNA microarray analyses, we found that expression of the ACPP gene increased significantly in the oviduct of young chicks treated with diethylstilbestrol (DES, a synthetic estrogen) [5] and in the oviduct of laying hens during the regeneration phase of oviduct remodeling [6] . In connection with previous study for estrogen-induced oviduct development, several researchers have suggested that aggressive epithelial ovarian carcinoma originates from cells of the oviduct of laying hens and is associated with up-regulation of oviduct-related genes in the cancerous ovaries [7] . Therefore, the hypothesis examined in the present study was that ACPP plays an essential role(s) in the growth, development, and differentiation of the chicken oviduct in response to estrogen. The objectives of this study were to 1) evaluate tissue-and cell-specific expression of ACPP in the female reproductive organs of chickens, 2) determine whether ACPP expression is regulated by estrogen during development of the chick oviduct, 3) determine whether ACPP expression is regulated by estrogen during the regression and recrudescence phases of induced molting, and 4) compare expression patterns of ACPP in normal and cancerous ovaries of laying hens and women. Results of the present study provide evidence that ACPP has pivotal roles in development of the oviduct of laying hens that is estrogen dependent and that it is a candidate gene for prognosis of epithelia-derived ovarian cancer in laying hens and women.
MATERIALS AND METHODS

Experimental Animals and Animal Care
The experimental use of chickens for this study was approved by the Animal Care and Use Committee of Korea University. All chickens were exposed to a light regimen of 15L:9D with ad libitum access to feed and water, and subjected to standard poultry husbandry guidelines.
Tissue Samples
Study one. Following euthanasia of 1-to 2-yr-old laying White Leghorn hens, tissue samples were collected from brain, heart, liver, kidney, small intestine, gizzard, muscle, ovary, and oviduct (n ¼ 5). Subsets of these samples were frozen or fixed in 4% paraformaldehyde for further analysis. Frozen tissue samples were cut into 5-to 7-mm pieces, frozen in liquid nitrogen vapor, and stored at À808C. The other samples were cut into 10-mm pieces and fixed in fresh 4% paraformaldehyde in PBS (pH 7.4). After 24 h, fixed tissues were changed to 70% ethanol for 24 h and then dehydrated and embedded in Paraplast-Plus (Leica Microsystems). Paraffin-embedded tissues were sectioned at 5 lm.
Study two. Female chicks were identified by PCR analysis using W chromosome-specific primer sets (F: 5 0 -CTA TGC CTA CCA CAT TCC TAT TTG C-3 0 and R: 5 0 -AGC TGG ACT TCA GAC CAT CTT CT-3 0 ). Treatment with DES and recovery of the oviduct were conducted as reported previously [8] . Based on experimental design of previous study, we treated DES with two steps. First of all, we implanted a 10-mg pellet of DES in the abdominal region of 1-wk-old female chicks to release the hormone for 10 days. The DES pellet was removed from all chicks for 10 days, and then a 10-mg pellet was administered for 10 additional days. Five chicks were assigned to each treatment group.
Study three. Molting of laying hens was induced by adding 20 000 ppm zinc to the diet to effectively reduce feed intake and induce molting [9, 10] . Briefly, molting was induced by feeding hens a diet containing high zinc (mixed 252 g zinc oxide per 10 kg feed to achieve a final concentration of 20 000 ppm of zinc). Laying hens in the molting group completely ceased egg production within 12 days after feeding the high-zinc diet. The 35 laying hens (47 wk old) were divided into two groups, a molting-progressing group and a postmolting-progressing group, and kept in individual cages. The molting group was further divided into three subgroups based on the number of days of feeding the high-zinc diet (normal feeding group and 6 and 12 days after onset of zinc feeding). The recrudescence (postmolting) group was divided into four subgroups based on the number of days from complete cessation of egg laying and initiation of feeding a normal commercial diet: 20, 25, 30, or 35 days after onset of zinc feeding or 8, 13, 18, or 23 days on normal feed after cessation of egg production and removal from the high-zinc diet.
Study four. In this study, a total of 136 laying hens (88 over 36 mo of age and 48 over 24 mo of age) that had stopped laying eggs were euthanized for collection of normal and cancerous ovaries. From that population of laying hens, we obtained cancerous ovarian tissue from 10 hens and normal ovarian tissues from 10 egg-laying hens of similar age. We evaluated tumor stage of 10 hens with cancerous ovaries according to characteristic features of chicken ovarian cancer [11, 12] . Three hens had stage III disease, as ovarian tumor cells had metastasized to the gastrointestinal (GI) tract and liver surface with profuse ascites in the abdominal cavity. Five hens had tumor cells spread to distant organs including liver parenchyma, lung, GI tract, and oviduct with profuse ascites, indicating stage IV disease. Two hens had stage I disease, as tumors were limited to their ovaries. Epithelial ovarian cancers in chickens were classified based on their cellular subtypes and patterns of cellular differentiation with reference to ovarian malignant tumor types in humans [11] .
RNA Isolation
Total cellular RNA was isolated from frozen tissues using Trizol reagent (Invitrogen) according to the manufacturer's recommendations. The quantity and quality of total RNA was determined by spectrometry and denaturing agarose gel electrophoresis, respectively.
Semiquantitative RT-PCR Analysis
The cDNA was synthesized from total cellular RNA (2 lg) using random hexamer (Invitrogen) and oligo (dT) primers and AccuPower RT PreMix (Bioneer). The cDNA was diluted (1:10) in sterile water before use in PCR. For ACPP, the forward primer (5 0 -GGC CAC CAA AGA TAC AGT GG-3 0 ) and reverse primer (5 0 -CCA ACA GCA ACA TCA AAT CC-3 0 ) amplified a 495-bp product. For GAPDH (housekeeping gene), the forward primer (5 0 -CAC AGC CAC ACA GAA GAC GG-3 0 ) and reverse primer (5 0 -CCA TCA AGT CCA CAA CAC GG-3 0 ) amplified a 443-bp product. The primers, PCR amplification, and verification of their sequences were conducted as described previously [13, 14] . PCR amplification was conducted using approximately 60 ng cDNA as follows: 1) 958C for 3 min; 2) 958C for 20 sec, 608C for 40 sec, and 728C for 1 min for 35 cycles; and 3) 728C for 10 min. After PCR, equal amounts of reaction product were analyzed using a 1% agarose gel, and PCR products were visualized using ethidium bromide staining. The amount of DNA present was quantified by measuring the intensity of light emitted from correctly sized bands under ultraviolet light using a Gel Doc XR þ system with Image Lab software (Bio-Rad).
Quantitative RT-PCR Analysis
Complementary DNA was synthesized using a Superscript III First-Strand Synthesis System (Invitrogen). Gene expression levels were determined using SYBR Green (Biotium) and a StepOnePlus Real-Time PCR System (Applied Biosystems). The GAPDH gene was analyzed simultaneously as a control and used for normalization to account for variation in loading. ACPP and GAPDH were analyzed in triplicate. Using the standard curve method, we determined the level of expression of the examined genes using the standard curves and C T values, and normalized them based on GAPDH expression. For ACPP, the forward primer (5 0 -ACA ATG GCA GTT GAC ACA GG-3 0 ) and reverse primer (5 0 -TAT CTT TGG TGG CCC ATA CC-3 0 ) amplified a 136-bp product. For GAPDH, the forward primer (5 0 -CAG AAC ATC ATC CCA GCG TC-3 0 ) and reverse primer (5 0 -GGC AGG TCA GGT CAA CAA CA-3 0 ) amplified a 133-bp product. The PCR conditions were 948C for 3 min, followed by 40 cycles at 948C for 20 sec, 608C for 40 sec, and 728C for 1 min using a melting curve program (increasing the temperature from 55 to 958C at 0.58C per 10 sec) and continuous fluorescence measurement. ROX dye (Invitrogen) was used as a negative control for the fluorescence measurements. Sequencespecific products were identified by generating a melting curve in which the Ct value represented the cycle number at which a fluorescent signal was statistically greater than background, and relative gene expression was quantified using the 2
ÀDDCt method [15] . The relative quantification of gene expression was normalized to the Ct value for the control oviduct.
In Situ Hybridization Analysis
For hybridization probes, PCR products were generated from cDNA with the primers used for RT-PCR analysis. The products were extracted from the gel and cloned into TOPO vector (Invitrogen). After verification of the sequences, plasmids containing gene sequences were amplified with T7-and SP6-specific primers (T7:5 0 -TGT AAT ACG ACT CAC TAT AGG G-3 0 ; SP6:5 0 -CTA TTT AGG TGA CAC TAT AGA AT-3 0 ) then digoxigenin (DIG)-labeled RNA probes were transcribed using a DIG RNA labeling kit (Roche Applied Science). Tissues were collected and fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned at 5 lm on aminopropyltriethoxysilanetreated (silanized) slides. The sections were then deparaffinized in xylene and rehydrated to diethylpyrocarbonate (DEPC)-treated water through a graded series of alcohol. The sections were treated with 1% Triton X-100 in PBS for 20 min and washed two times in DEPC-treated PBS. After washing in DEPCtreated PBS, the sections were digested with 5 lg/ml Proteinase K (Sigma) in TE buffer (100 mM Tris-HCl, 50 mM EDTA, pH 8.0) at 378C. After postfixation in 4% paraformaldehyde, sections were incubated twice for 5 min each in DEPC-treated PBS and incubated in TEA buffer (0.1 M triethanolamine) containing 0.25% (v/v) acetic anhydride. The sections were incubated in a prehybridization mixture containing 50% formamide and 43 standard saline citrate (SSC) for at least 10 min at room temperature. After prehybridization, the sections were incubated overnight at 428C in a humidified chamber in a hybridization mixture containing 40% formamide, 43 SSC, 10% dextran sulfate sodium salt, 10 mM dithiothreitol, 1 mg/ml yeast tRNA, 1 mg/ml salmon sperm DNA, 0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.2 mg/ml RNase-free bovine serum albumin, and denatured DIG-labeled cRNA probe. After hybridization, sections were washed for 15 min in 23 SSC at 378C, 15 min in 13 SSC at 378C, 30 min in NTE buffer (10 mM Tris, 500 mM NaCl, and 1 mM EDTA) at 378C, and 30 min in 0.13 SSC at 378C. After blocking with 2% normal sheep serum (Santa Cruz Biotechnology, Inc.), the sections were incubated overnight with sheep anti-DIG antibody conjugated to alkaline phosphatase (Roche). The signal was visualized following exposure to a solution containing 0.4 mM 5-bromo-4-chloro-3-indolyl phosphate, 0.4 mM nitroblue tetrazolium, and 2 mM levamisole (Sigma Chemical Co.).
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Immunohistochemistry
Immunocytochemical localization of ACPP protein was performed as described previously using a rabbit polyclonal antibody to ACPP (catalog number 15840-1-AP; Proteintech Group, Inc.) at a final dilution of 1:100 (2.7 lg/ml). The amino acids 27-373 of human ACPP were the peptide used to raise the antibody. This region of human ACPP has 58% homology to chicken ACPP protein. Antigen retrieval was performed using the boiling citrate method as described previously [16] . Negative controls included substitution of the primary antibody with purified nonimmune rabbit immunoglobulin G (IgG) at the same final concentration. For immunohistochemistry of human ovarian cancer tissues, representative core tissue sections (4 mm in diameter) were taken from paraffin blocks and arranged in new tissue microarray (TMA) blocks using the trephine apparatus (Superbiochips Laboratories). Immunohistochemical procedure to detect ACPP in laying hen was similar to that used for immunohistochemical analyses of human TMA samples.
Statistical Analyses
Data for real-time PCR are expressed as mean 6 SEM unless otherwise stated. Differences in the variances between states of regression and recrudescence of the oviducts were analyzed using the F test, and differences between means were subjected to the Student t-test. Differences with a probability value of P , 0.05 were considered statistically significant.
RESULTS
Estrogen Regulates ACPP Gene Expression During the Development of the Chicken Oviduct
In humans, expression of ACPP is not limited to prostate tissues; rather, it is widely expressed in various tissues, including small intestine, spleen, and thymus [17] . In a preliminary experiment, we found moderate levels of expression of ACPP mRNA in brain, heart, liver, kidney, gizzard, and small intestine of male and female chickens, and higher expression in testis and oviduct (data not shown). Based on the abundant expression of ACPP in the oviduct and results from differential gene profiling of the chicken oviduct treated with DES [5] and oviductal remodeling and recrudescence in response to estrogen [6] , we focused on ACPP in the chicken oviduct. To determine whether estrogen regulates expression of ACPP during development and maturation of the chicken oviduct, we performed quantitative PCR analysis on tissue from the infundibulum, magnum, isthmus, and shell gland of the oviducts of neonatal female chicks treated with DES. As illustrated in Figure 1A , ACPP mRNA increased 21-fold (P , 0.05) in the oviduct of DES-treated chicks as compared to the nontreated chicks. Of particular note, ACPP mRNA increased 37-(P , 0.001), 30-(P , 0.001) and 26-fold (P , 0.001) in the magnum, isthmus, and shell gland portions of DES-treated chick oviduct, respectively (Fig. 1B) . Expression of ACPP mRNA was abundant in luminal (LE) and glandular epithelial cells (GE) of the isthmus and shell gland and LE of the magnum, and to a lesser degree in LE of the infundibulum from DES-treated chicks ( Fig. 2A) . Likewise, ACPP protein was localized in LE and GE the magnum, isthmus, and shell gland (Fig. 2B) . The nonspecific rabbit IgG used as a negative control did not detect ACPP protein in the tissues examined. These results indicate that estrogen enhances ACCP gene expression in the development and cytodifferentiation of the chicken oviduct.
Estrogen Regulates ACPP Expression in the Oviduct of Laying Hens During Induced Molting
An induced molting model developed in our laboratory was used to examine morphological and physiological changes in the oviduct and ovary of laying hens undergoing regression, remodeling, and recrudescence in response to estrogen [6] . Indeed, concentrations of estrogen in serum decreased during the induced molting period (Days 0 to 20) and increased during the recrudescence period (Days 20 to 35) after laying hens were fed a normal commercial feed [6] . As shown in Figure 3 , A and B, ACPP expression decreased (P , 0.001) from Day 6 to Day 20 (regression phase) and then increased (P , 0.001) between Days 25 and 35 (regeneration phase) of the oviduct of laying hens undergoing molting. In situ hybridization and immunohistochemical analyses revealed that ACPP mRNA and protein were localized predominantly to LE and GE of the oviduct during the regeneration phase of induced molting (Fig. 4, A  and B) . These results suggest that estrogen regulates expression of the ACPP gene during the processes of tissue regression and regeneration of the oviduct of laying hens during molting.
FIG. 1. A, B)
Effect of DES on tissue specificity of expression of ACPP mRNA in chickens. Q-PCR analyses were performed using cDNA templates from DES-treated and nontreated chicken oviducts (mean 6 SEM; *P , 0.05 or ***P , 0.001). These experiments were conducted in triplicate and normalized to control GAPDH expression. See Materials and Methods for complete description. 
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Distinct Expression Pattern of ACPP in Normal and Cancerous Ovaries of Hens and Women
As illustrated in Figure 5 , ACPP mRNA increased 7-fold (P , 0.001) in cancerous as compared to normal ovaries of laying hens, and abundant levels of ACPP mRNA and protein were detected specifically in GE of cancerous ovaries, but not stromal cells and blood vessels of cancerous ovaries or normal ovaries (Fig. 6, A and B) . In addition, there was strong expression of ACPP protein in cytoplasm of epithelial cells from epithelial-derived ovarian cancers, but not in any cell type of normal ovaries (Fig. 7) .
DISCUSSION
In the present study, we demonstrated that ACPP expression in the female reproductive tract of chickens is estrogen dependent. Furthermore, results of the present study provide   FIG. 3 . Quantitation of ACPP mRNA during regression and recrudescence of the magnum of the oviducts from laying hens during induced molting. Quantitative RT-PCR was conducted using cDNA templates from the magnum of hens fed a control diet (Day 0), hens fed a high-zinc diet in which the oviduct was regressing (Days 6-12; A) , and hens in which the oviduct was undergoing recrudescence (Days 20, 25, 30, and 35; B) . These experiments were performed in triplicate and normalized to control GAPDH expression. The asterisks denote statistically significant differences (mean 6 SEM; *P , 0.05 or ***P , 0.001). See Materials and Methods for complete description.
FIG. 4.
Cell-specific localization of ACPP mRNA and protein during regression and recrudescence of the magnum of the oviducts from laying hens during induced molting. A) The localization of ACPP mRNA in the magnum of hens on different days of the regression phase and the recrudescence phase was analyzed by in situ hybridization. Cross sections of the magnum of the oviducts were hybridized with either an antisense or sense chicken ACPP cRNA probe. B) Immunoreactive ACPP protein in the magnum during the regression phase and recrudescence phase was analyzed by immunohistochemistry. For the IgG control, normal rabbit IgG was substituted for the primary antibody. Sections were not counterstained. Bars ¼ 50 lm (the first and third horizontal panels) and 20 lm (the second and fourth horizontal panels). See Materials and Methods for complete description.
ESTROGEN REGULATES AVIAN ACPP GENE the first evidence for induction and stimulation of ACPP expression in ovarian carcinomas of laying hens and women. Collectively, these results strongly support our hypothesis that ACPP plays an important role(s) in the development and cytodifferentiation of the oviduct in response to estrogen in laying hens and that its overexpression may be involved in progression from a normal ovary to ovarian carcinogenesis in laying hens and women.
In the human genome, the ACPP gene has 10 exons and is located on chromosome 3q21 [17] . Structurally, ACPP has two subunits that form a homodimer and its phosphatase activity is activated in acidic conditions [18] . After mRNA translation and the cleavage event, the mature and active ACPP polypeptide has 354 residues [19] and each monomer contains six cysteine residues that form three disulfide bonds: Cys129-Cys340, Cys183-Cys281, and Cys315-Cys319 [20] . The avian ACPP gene has high sequence identity with ACPP genes of panther (99%), monkey (94%), and cow (81%) [2] . Surprisingly, apart from prostate gland, ACPP has been purified from placenta [21] , liver [22] , and other human tissues such as brain, kidney, liver, lung, and spleen [23] . Consistent with these results, we found that ACPP is expressed in various organs of chickens. These results indicate that ACPP expression is not limited to the prostate gland, but is widely expressed in various tissues in vertebrates.
The chicken oviduct is one of the best classical models to examine physiological effects of steroid hormones on development and differentiation of tissues/organs in the animal body [24] . During the developing oviduct of laying hens, estrogen is the primary sex steroid hormone that plays essential roles in the oviduct that include 1) cell proliferation and cytodifferentiation; 2) synthesis, storage, and secretion of egg white proteins in the magnum; and 3) morphological change and differentiation of tubular glands [25] . In fact, DES implants induce development and maturation of the neonatal chick oviduct and accompanying cytodifferentiation of oviductal tubular glands, FIG. 5 . Quantitation of ACPP mRNA between normal and cancerous ovaries from laying hens. Quantitative PCR was conducted using cDNA templates from normal and cancerous ovaries of hens. These experiments were performed in triplicate and normalized to control GAPDH expression. The asterisks denote statistically significant differences (mean 6 SEM; ***P , 0.001). and normal production and secretion of egg white proteins by epithelial cells of the magnum [26] . Our gene profiling data revealed that ACPP increased in the oviduct of chicks treated with a DES implant [5] . Our present study demonstrated that estrogen stimulates ACCP in LE and GE of the magnum, isthmus, and shell gland during development and differentiation of the chicken oviduct. Previous reports indicated that ACPP is synthesized and secreted by columnar epithelia cells of the human prostate gland [3] . We also identified ACPP as an estrogen-regulated gene associated with regulatory mechanisms for regression and recrudescence of the oviduct of laying hens during induced molting [6] . Indeed, induced molting leads to regression and remodeling of the oviduct in laying hens and thus regulation of temporal expression patterns of many genes responsive to changing concentrations of estrogen in blood following cessation and reinitiation of ovarian steroidogenesis [6] . Results of the present study showed that ACPP mRNA and protein decrease during the induced molting period (Days 0-20) and then increase during the recrudescence period (Days 20-35) in a manner that is coordinated with changes in concentrations of estradiol in serum. Collectively, these results suggest that ACPP is a novel estrogen-stimulated gene during development and differentiation of the immature chick oviduct, and it appears to also be involved in remodeling/regeneration of the oviduct in response to estrogen during the molting period in laying hens.
There are currently markers for prostate cancer including ACPP and prostate-specific antigen (PSA). Although ACPP was the earliest biochemical indicator discovered in the circulation of prostate cancer patients in 1938 [27] , it became obsolete as a marker because of its inferiority to PSA [28] . However, ACPP is a good independent predictor for patients at high risk for tumor recurrence following radical retropubic prostatectomy [29] . Expression of ACPP is believed to be regulated by androgens, but its regulatory mechanism(s) at the molecular and endocrinological level is not completely understood. Recently, it has been reported that pelvic serous cancer (ovarian cancer) may originate from the distal end of the oviduct [30] . Among ovarian cancers, epithelial cell-derived ovarian cancer (EOC) is one of the most lethal cancers in women [31] , but an effective animal model to develop novel biomarkers for early detection of EOC remains to be identified.
Laying hens are being recognized as one of the best animal models for EOC, because carcinoma progression and histological/pathological types and stages are very similar to those in women [11, 32] . In addition, chicken EOC may arise from the oviduct, and a number of common genes are up-regulated in EOC and in the oviduct in response to estrogen stimulation in the laying hen model [33] . Indeed, we reported expression of several estrogen-stimulated genes in cancerous ovaries of laying hens that include cathepsin B (CTSB) [34] , serpin peptidase inhibitor, clade B, member 11 (SERPINB11) [12] , SERPINB3 [35] , S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) [36] , secreted phosphoprotein 1 (SPP1) [12] , alpha 2 macroglobulin (A2M) [37] , pleiotrophin (PTN) [38] , beta-defensin 11 (AvBD-11) [39] , beta-catenin (CTNNB1) [40] , and several cell cycle genes [41] that are also mainly expressed in the chicken oviduct. Likewise, our current results indicate that expression of ACPP mRNA and protein increase significantly in GE of cancerous, but not normal, ovaries of laying hens. These results indicate that ACPP expression is very similar to that of estrogen receptor alpha (ESR1) mRNA and protein, which increase significantly in GE of cancerous, but not normal, ovaries. These results suggest that the ACPP gene is estrogen stimulated in cancerous ovaries of laying hens. Moreover, immunohistochemical analysis for ACPP shows that the protein is abundant in epithelial cells of epithelial-derived ovarian cancer, especially serous and mucinous carcinomas, as compared with normal ovaries from women. Thus, ACPP may play a pivotal role(s) in the development of EOC in laying hens and women and serve as a biomarker for early detection and monitoring of therapies used to treat EOC in women, as it was used previously as a marker of prostate cancer in men.
In conclusion, results of the present study demonstrate that ACPP is a novel estrogen-stimulated gene expressed specifically in LE and GE of the oviduct during morphological and physiological maturation. Moreover, ACPP is an essential regulatory factor associated with abnormal growth and dysfunction of ovarian tumor progression. Therefore, our results provide new insight into the use of ACPP as a biomarker for diagnosis and monitoring of effectiveness of therapies for treatment of EOC in laying hens and women. 
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